Deferred Tax Assets, Valuation Allowance of Silo Pharma, Inc. from 31 Dec 2011 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Silo Pharma, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2024.
  • Silo Pharma, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $3,710,726, a 46% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Silo Pharma, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $3,710,726 +$1,172,161 +46% 31 Dec 2024 10-K 28 Mar 2025 2024 FY
Q4 2023 $2,538,565 +$988,177 +64% 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q4 2022 $1,550,388 +$940,858 +154% 31 Dec 2022 10-K 25 Mar 2024 2023 FY
Q4 2021 $609,530 -$382,741 -39% 31 Dec 2021 10-K 24 Mar 2023 2022 FY
Q4 2020 $992,271 +$377,520 +61% 31 Dec 2020 10-K/A 17 May 2021 2020 FY
Q4 2019 $614,751 +$116,258 +23% 31 Dec 2019 10-K/A 17 May 2021 2020 FY
Q4 2018 $498,493 +$189,965 +62% 31 Dec 2018 10-K 20 Mar 2020 2019 FY
Q4 2017 $308,528 31 Dec 2017 10-K 04 Apr 2019 2018 FY
Q4 2013 $22,000 +$14,000 +39% 31 Dec 2013 10-K 31 Mar 2014 2013 FY
Q4 2012 $36,000 -$57,000 -271% 31 Dec 2012 10-K 31 Mar 2014 2013 FY
Q4 2011 $21,000 31 Dec 2011 10-K 05 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.